A Fracture Liaison Service (FLS) is a specific model of care where a coordinator pro-actively identifies fracture patients, on a system-wide basis, and determines their fracture risk with the express […]

BC ADVOCACY Osteoporosis Canada together with British Columbia Coalition of Osteoporosis Physicians (BCCOP) and Medicines Access Coalition – BC (MedAccess BC) are working together to advocate for British Columbians at […]

Accessibility Accessibility Accessibility for Ontarians With Disabilities Act (AODA) Accessibility for Ontarians With Disabilities Act (AODA) Osteoporosis Canada is committed to excellence in servicing all customers including people with disabilities. […]

Since the COVID-19 lockdown began and even now as things begin to open up across the country, many health professionals have been consulting with their patients on-line or on the […]

A recently released Canadian research study confirms what has been shown in past preliminary studies; – inflammation of the eye as a possible side effect of bisphosphonate therapy is very […]

It is well known that calcium is a necessary nutrient because it plays an essential role in human health, not only for bone development but also for the heart, muscle […]

Contributors: Dr. Adrian Lau, Dr. Claudia Gagnon, Dr. Laëtitia Michou, Dr. Emma Billington, Dr. Zahra Bardai, Dr. Dr. Vithika Sivabalasundaram, Dr. Rowena Ridout, Dr. Sandra Kim, Dr. Suzanne Morin Recommendations […]

OSTEOPOROSIS AND OSTEOARTHRITIS The prefix “osteo” (which means “bone”) is the only thing that osteoporosis and osteoarthritis have in common. Despite the fact that osteoporosis, arthritis and osteoarthritis (a form […]

Latest News Sandoz receives Health Canada approval for Jubbonti®, first and only denosumab biosimilar for treatment of osteoporosis. May 31, 2024 Health Canada has provided authorization to market Jubbonti® (denosumab […]